Evidence map›Paper›PMID 18270820›Full record

ArticleNeurochemical research2008

Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets.

M L Trincavelli, S Cuboni, M Montali, S Santaguida, A Lucacchini, C Martini

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M L TrincavelliDepartment of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
S Cuboni
M Montali
S Santaguida
A Lucacchini
C Martini
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptive changes in serotonergic 5HT1 receptor signalling are believed to underlie the therapeutic effectiveness of antidepressant drugs. Since cells are continuously exposed to neurotransmitters/neuromodulators, spatially and temporally integrated, the responsiveness of a receptor system is dependent upon the physio-pathological state of the cell and the interaction between different neurotransmitters. In the present work, we investigated heterologous regulation of 5HT1 receptors induced by norepinephrine (NE) in human platelets. NE platelet treatment induced a time and concentration dependent 5HT1 receptor desensitisation mediated by both alpha and beta receptors through activation of intracellular protein kinases. In particular NE, through PKC activation, regulated 5HT1 receptor phosphorylation on threonine residues, causing in turn serotonin receptor-G protein uncoupling and functional responsiveness drop. These results suggest that high NE levels (released i.e. during stress disorders) may play an important role in regulating the 5HT1 responsiveness and in controlling effectiveness of drugs acting on these neurotransmitter systems.

Indexed as

Adenylyl CyclasesAdrenergic alpha-AntagonistsAdrenergic beta-AntagonistsBlood PlateletsCyclic AMP-Dependent Protein KinasesData Interpretation, StatisticalEnzyme InhibitorsGuanosine 5'-O-(3-Thiotriphosphate)HumansIn Vitro TechniquesKineticsNorepinephrinePhentolaminePhosphoinositide-3 Kinase InhibitorsPhosphorylationPropranololAdenylyl CyclasesAdrenergic alpha-AntagonistsAdrenergic beta-AntagonistsCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsGuanosine 5'-O-(3-Thiotriphosphate)NorepinephrinePhentolaminePhosphoinositide-3 Kinase InhibitorsPropranololProtein Kinase CReceptors, G-Protein-CoupledReceptors, Serotonin, 5-HT1

Identifiers

PMID18270820
OpenAlexW2094860317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.